The decision to continue, adjust, or discontinue therapy should be individualized based on the underlying cause of back pain and the overall benefit-risk assessment
Furthermore, alcohol can impair judgment and decision-making, potentially leading to medication non-adherence or unsafe behaviors
Heres what to actually watch for: Common (usually mild): Mild nausea, especially in the first 48 hours after injection Reduced appetite (this is the goal, but can go too far) Fatigue during the first two weeks Constipation or occasional loose stools Injection site irritation Less common but real: Hair thinning, usually tied to rapid weight loss rather than the drug itself Muscle loss if protein intake drops Gallbladder issues in patients with pre-existing risk Mood shifts (both directions have been reported) Serious (rare but require attention): Pancreatitis Severe dehydration Allergic reactions to the compounded formulation Is microdosing semaglutide safe
With an 84% success rate, compared with other gastric balloons in the US, the Spatz3 can provide quick results
Individualized Approach Your genetics, age, sex, baseline weight, and metabolic rate all play a role in how your body responds to semaglutide GLP-1